Myanmar receives its first 1.5 million doses of the Oxford-AstraZeneca COVID-19 vaccine manufactured by the Serum Institute of India
Myanmar receives its first 1.5 million doses of the Oxford-AstraZeneca COVID-19 vaccine manufactured by the Serum Institute of India.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthMyanmar receives its first 1.5 million doses of the Oxford-AstraZeneca COVID-19 vaccine manufactured by the Serum Institute of India
View Premium plansBrowse free archive reportsMyanmar receives its first 1.5 million doses of the Oxford-AstraZeneca COVID-19 vaccine manufactured by the Serum Institute of India.